Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR
Ma. Poussin et al., Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR, J NEUROIMM, 111(1-2), 2000, pp. 152-160
To analyze the role of interleukin-10 (IL-10) in experimental autoimmune my
asthenia gravis (EAMG) pathogenesis, we induced clinical EAMG in C57BL/6 an
d IL-10 gene-knockout (KO) mice. LL-IO KO mice had a Lower incidence and se
verity of EARAG, with less muscle acetylcholine receptor (AChR) loss. AChR-
immunized IL-10 KO mice showed a significantly higher AChR-specific prolife
rative response, altered cytokine response, lower number of class II-positi
ve cells and B-cells, but a greater CD5(+)CD19(+) population than C57BL/6 m
ice. The lower clinical incidence in IL-10 KO could be explained not by a r
eduction of the quantity, but by a possible difference in the pathogenicity
of anti-AChR antibodies. (C) 2000 Published by Elsevier Science B.V.